Lymph node ratio in melanoma: A marker of variation in surgical quality?

Cancer

Volumn 115, Issue 11, 2009, Pages 2384-2387

  Spillane, Andrew J ^a,b   Winstanley, Julie ^a   Thompson, John F ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; DISEASE MARKER; EDITORIAL; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE RATIO; MELANOMA; MINIMAL RESIDUAL DISEASE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SURVIVAL; UNITED STATES;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 66649113968     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24295     Document Type: Editorial

References (20)

1. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26:4296-4303.
2. Morton D, Thompson J, Cochran A, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317. (Pubitemid 44465459)
3. Morton D. Phase III randomized study of complete lymph node dissection versus observation in patients with localized cutaneous melanoma and sentinel node metastasis who have undergone sentinel lymphadenectomy. 2006. Available at: http://www.clinicaltrials.gov/ct2/show/NCT00389571?term= MSLT+II%2C+melanoma&rank=1. Accessed on March 12, 2009.
4. vanAkkooi A, de Wilt JD, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17:1578-1585.
5. Satzger I, Volker B, Meier A, et al. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol. 2007;31:1175-1180. (Pubitemid 47207119)
6. Bilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008;15:1566-1576.
7. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. melanoma. Vol.2. 2008. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/melanoma.pdf
8. Surveillance, Epidemiology, and End Results. About SEER. Available at: http://seer.cancer.gov/about Accessed November 21, 2008.
9. Xing Y, Badgwell B, Ross M, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115:2505-2513.
10. International Nodal Ratio Working Group. Available at: http://inrwg.org Accessed November 21, 2008.
11. Woodward WA, Vinh-Hung V, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24:2910-2916. (Pubitemid 46630594)
12. Truong PT, Vinh-Hung V, Cserni G, et al. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer. 2008;44:1670-1677.
13. Rossi CR, Mocellin S, Pasquali S, et al. N-Ratio: A novel independent prognositc factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15:310-315.
14. Katz A, Buchholz TA, Thames H, et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys. 2001;50:397-403. (Pubitemid 32472268)
15. Thompson J, Morton D, Kroon B. Textbook of Melanoma. London:Martin Dunitz; 2004.
16. Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg. 1983;198:164-167.
17. Spillane A, Cheung B, Stretch J, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249:473-480.
18. Kretschmer L, Preusser K. Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma. Langenbecks Arch Surg. 2001;386:418-425. (Pubitemid 33140748)
19. Lee CC, Faries MB, Wanek LA, Morton DL. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma. J Clin Oncol. 2008;26:535-541.
20. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003;44:570-582. (Pubitemid 39663425)